Free Trial

Roanna Ruiz Analyst Performance

Analyst at Williams Trading

Roanna Ruiz is a stock analyst at Williams Trading in the healthcare sector, covering 15 publicly traded companies. Over the past year, Roanna Ruiz has issued 21 stock ratings, including buy and hold recommendations. While full access to Roanna Ruiz's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Roanna Ruiz's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
31 Last 3 Years
Buy Recommendations
88.89% 24 Buy Ratings
Companies Covered
15 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy88.9%24 ratings
Hold11.1%3 ratings
Sell0.0%0 ratings

Out of 27 total stock ratings issued by Roanna Ruiz at Williams Trading, the majority (88.9%) have been Buy recommendations, followed by 11.1% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
15 companies

Roanna Ruiz, an analyst at Williams Trading, currently covers 15 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
15 companies
100.0%

Roanna Ruiz of Williams Trading specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
10 companies
66.7%
PHARMACEUTICALS
5 companies
33.3%

Roanna Ruiz's Ratings History at Williams Trading

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
11/5/2026Lower Price Target$55.15$100.00Outperform
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
10/19/2026Boost Price Target$541.03$725.00Outperform
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
10/7/2026Lower Price Target$2.57$4.00Market Perform
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
9/23/2026Reiterated Rating$4.01$15.00Outperform
Xeris Biopharma Holdings, Inc. stock logo
XERS
Xeris Biopharma
9/10/2026Boost Price Target$7.71$16.00Outperform
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
9/8/2026Set Price Target$5.62$15.00
Akebia Therapeutics, Inc. stock logo
AKBA
Akebia Therapeutics
8/7/2026Downgrade$0.95$1.00Market Perform
KARD
Kardigan
7/13/2026Initiated Coverage$24.64$37.00Outperform
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
6/25/2026Lower Price Target$7.91$24.00Outperform
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
6/3/2026Boost Price Target$8.86$21.00Outperform
CorMedix Inc stock logo
CRMD
CorMedix
4/28/2026Boost Price Target$7.82$14.00Outperform
Ardelyx, Inc. stock logo
ARDX
Ardelyx
3/12/2026Set Price Target$5.66$17.00
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
3/10/2026Reiterated Rating$63.94Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
3/10/2026Set Price Target$64.23$84.00
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
3/10/2026Set Price Target$9.39$26.00Outperform
CorMedix Inc stock logo
CRMD
CorMedix
3/6/2026Reiterated Rating$6.46$13.00Outperform
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
2/26/2026Reiterated Rating$9.35$20.00Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
2/26/2026Boost Price Target$62.80$84.00Outperform
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
1/6/2026Reiterated Rating$33.48$55.00Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
12/22/2025Set Price Target$68.34$83.00
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
11/19/2025Boost Price Target$11.31$16.00Outperform
iBio, Inc. stock logo
IBIO
iBio
10/17/2025Initiated Coverage$0.85$2.00Outperform
Xeris Biopharma Holdings, Inc. stock logo
XERS
Xeris Biopharma
8/19/2025Boost Price Target$7.59$9.00Outperform
Akebia Therapeutics, Inc. stock logo
AKBA
Akebia Therapeutics
4/28/2025Initiated Coverage$2.38$7.00Outperform
CorMedix Inc stock logo
CRMD
CorMedix
3/7/2025Initiated Coverage$9.49$18.00Outperform
Xeris Biopharma Holdings, Inc. stock logo
XERS
Xeris Biopharma
3/7/2025Boost Price Target$4.19$6.00Outperform
Lexicon Pharmaceuticals, Inc. stock logo
LXRX
Lexicon Pharmaceuticals
3/4/2025Reiterated Rating$0.32$1.00Market Perform
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
1/13/2025Boost Price Target$10.71$20.00Outperform
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
1/13/2025Boost Price Target$11.97$27.00Outperform